Old and new findings on lipopolysaccharide-binding protein: A soluble pattern-recognition molecule

Biochemical Society Transactions

Volumn 39, Issue 4, 2011, Pages 989-993

  Schumann, Ralf R ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Acute phase protein; Endotoxin recognition; Innate immunity; Lipopolysaccharide binding protein (LBP); Single nucleotide polymorphism (SNP)

Indexed keywords

ACUTE PHASE PROTEIN; LIPOPEPTIDE; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; PHOSPHOLIPID TRANSFER PROTEIN; TOLL LIKE RECEPTOR;

BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; BORRELIA; CONFERENCE PAPER; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GRAM NEGATIVE BACTERIUM; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LIVER; NONHUMAN; PANCREATITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STREPTOCOCCUS PNEUMONIAE; TREPONEMA;

ACUTE-PHASE PROTEINS; ANIMALS; BACTERIAL INFECTIONS; BACTERIAL PROTEINS; CARRIER PROTEINS; GENETIC VARIATION; HUMANS; IMMUNITY, INNATE; MEMBRANE GLYCOPROTEINS; STRUCTURAL HOMOLOGY, PROTEIN;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 79960854565     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0390989     Document Type: Conference Paper

References (90)

1. Tobias, P.S., Soldau, K. and Ulevitch, R.J. (1986) Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J. Exp. Med. 164, 777-793
2. Tobias, P.S., Mathison, J.C. and Ulevitch, R.J. (1988) A family of lipopolysaccharide binding proteins involved in responses to Gram-negative sepsis. J. Biol. Chem. 263, 13479-13481
3. Tobias, P.S., Soldau, K. and Ulevitch, R.J. (1989) Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. J. Biol. Chem. 264, 10867-10871
4. Schumann, R.R., Leong, S.R., Flaggs, G.W., Gray, P.W., Wright, S.D., Mathison, J.C., Tobias, P.S. and Ulevitch, R.J. (1990) Structure and function of lipopolysaccharide binding protein. Science 249, 1429-1431 (Pubitemid 120034117)
5. Marra, M.N., Wilde, C.G., Collins, M.S., Snable, J.L., Thornton, M.B. and Scott, R.W. (1992) The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin. J. Immunol. 148, 532-537
6. Wright, S.D., Ramos, R.A., Tobias, P.S., Ulevitch, R.J. and Mathison, J.C. (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249, 1431-1433
7. Pugin, J., Schurer-Maly, C.C., Leturcq, D., Moriarty, A., Ulevitch, R.J. and Tobias, P.S. (1993) Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. U.S.A. 90, 2744-2748
8. Viriyakosol, S., Tobias, P.S., Kitchens, R.L. and Kirkland, T.N. (2001) MD-2 binds to bacterial lipopolysaccharide. J. Biol. Chem. 276, 38044-38051
9. Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K. and Kimoto, M. (1999) MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189, 1777-1782
10. Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K. and Akira, S. (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the LPS gene product. J. Immunol. 162, 3749-3752 (Pubitemid 29314747)
11. Chow, J.C., Young, D.W., Golenbock, D.T., Christ, W.J. and Gusovsky, F. (1999) Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274, 10689-10692
12. Poltorak, A., He, X., Smirnova, I., Liu, M.Y., Van Huffel, C., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C. et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088 (Pubitemid 29001265)
13. Poltorak, A., Smirnova, I., He, X., Liu, M.Y., Van Huffel, C., McNally, O., Birdwell, D., Alejos, E., Silva, M., Du, X. et al. (1998) Genetic and physical mapping of the LPS locus: identification of the Toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol. Dis. 24, 340-355
14. Gioannini, T.L., Teghanemt, A., Zarember, K.A. and Weiss, J.P. (2003) Regulation of interactions of endotoxin with host cells. J. Endotoxin Res. 9, 401-408 (Pubitemid 38035606)
15. Weiss, J. (2003) Bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP): structure, function and regulation in host defence against Gram-negative bacteria. Biochem. Soc. Trans. 31, 785-790
16. Gray, P.W., Corcorran, A.E., Eddy, Jr, R.L., Byers, M.G. and Shows, T.B. (1993) The genes for the lipopolysaccharide binding protein (LBP) and the bactericidal permeability increasing protein (BPI) are encoded in the same region of human chromosome 20. Genomics 15, 188-190 (Pubitemid 23079591)
17. Hubacek, J.A., Buchler, C., Aslanidis, C. and Schmitz, G. (1997) The genomic organization of the genes for human lipopolysaccharide binding protein (LBP) and bactericidal permeability increasing protein (BPI) is highly conserved. Biochem. Biophys. Res. Commun. 236, 427-430
18. Kirschning, C.J., Au-Young, J., Lamping, N., Reuter, D., Pfeil, D., Seilhamer, J.J. and Schumann, R.R. (1997) Similar organization of the lipopolysaccharide-binding protein (LBP) and phospholipid transfer protein (PLTP) genes suggests a common gene family of lipid-binding proteins. Genomics 46, 416-425 (Pubitemid 28063290)
19. Bingle, C.D. and Craven, C.J. (2004) Meet the relatives: a family of BPI-and LBP-related proteins. Trends Immunol. 25, 53-55 (Pubitemid 38167484)
20. Tall, A., Sharp, D., Zhong, S., Hayek, T., Masucci-Magoulas, L., Rubin, E.M. and Breslow, J.L. (1997) Cholesteryl ester transfer protein and atherogenesis. Ann. N.Y. Acad. Sci. 811, 178-182
21. Tall, A.R. and Lalanne, F. (2003) Phospholipid transfer protein and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 23, 1484-1485
22. Boekholdt, S.M., Kuivenhoven, J.A., Hovingh, G.K., Jukema, J.W., Kastelein, J.J. and van Tol, A. (2004) CETP gene variation: relation to lipid parameters and cardiovascular risk. Curr. Opin. Lipidol. 15, 393-398
23. Aouizerat, B.E., Engler, M.B., Natanzon, Y., Kulkarni, M., Song, J., Eng, C., Huuskonen, J., Rivera, C., Poon, A., Bensley, M. et al. (2006) Genetic variation of PLTP modulates lipoprotein profiles in hypoalphalipoproteinemia. J. Lipid Res. 47, 787-793
24. Weston, W.M., LeClair, E.E., Trzyna, W., McHugh, K.M., Nugent, P., Lafferty, C.M., Ma, L., Tuan, R.S. and Greene, R.M. (1999) Differential display identification of plunc, a novel gene expressed in embryonic palate, nasal epithelium, and adult lung. J. Biol. Chem. 274, 13698-13703
25. Bingle, C.D. and Bingle, L. (2000) Characterisation of the human plunc gene, a gene product with an upper airways and nasopharyngeal restricted expression pattern. Biochim. Biophys. Acta. 1493, 363-367
26. LeClair, E.E., Nguyen, L., Bingle, L., MacGowan, A., Singleton, V., Ward, S.J. and Bingle, C.D. (2001) Genomic organization of the mouse plunc gene and expression in the developing airways and thymus. Biochem. Biophys. Res. Commun. 284, 792-797
27. Bingle, C.D. and Craven, C.J. (2002) PLUNC: a novel family of candidate host defence proteins expressed in the upper airways and nasopharynx. Hum. Mol. Genet. 11, 937-943
28. He, Y., Zhou, G., Zhai, Y., Dong, X., Lv, L., He, F. and Yao, K. (2005) Association of PLUNC gene polymorphisms with susceptibility to nasopharyngeal carcinoma in a Chinese population. J. Med. Genet. 42, 172-176
29. Beamer, L.J., Carroll, S.F. and Eisenberg, D. (1998) The BPI/LBP family of proteins: a structural analysis of conserved regions. Protein Sci. 7, 906-914 (Pubitemid 28216532)
30. Beamer, L.J., Carroll, S.F. and Eisenberg, D. (1997) Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. Science 276, 1861-1864
31. Beamer, L.J. (2003) Structure of human BPI (bactericidal/permeability- increasing protein) and implications for related proteins. Biochem. Soc. Trans. 31, 791-794
32. 99) of lipopolysaccharide (LPS)-binding protein on binding and transfer of LPS and subsequent immune cell activation. J. Immunol. 157, 4648-4656
33. Han, J., Mathison, J.C., Ulevitch, R.J. and Tobias, P.S. (1994) Lipopolysaccharide (LPS) binding protein, truncated at Ile-197, binds LPS but does not transfer LPS to CD14. J. Biol. Chem. 269, 8172-8175
34. Schumann, R.R., Lamping, N. and Hoess, A. (1997) Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities. J. Immunol. 159, 5599-5605 (Pubitemid 127470090)
35. Bingle, C.D., LeClair, E.E., Havard, S., Bingle, L., Gillingham, P. and Craven, C.J. (2004) Phylogenetic and evolutionary analysis of the PLUNC gene family. Protein Sci. 13, 422-430
36. Gallay, P., Carrel, S., Glauser, M.P., Barras, C., Ulevitch, R.J., Tobias, P.S., Baumgartner, J.D. and Heumann, D. (1993) Purification and characterization of murine lipopolysaccharide-binding protein. Infect. Immun. 61, 378-383
37. 36a Wittmann, I., Schönefeld, M., Aichele, D., Groer, G., Gessner, A. and Schnare, M. (2008) Murine bactericidal/permeability-increasing protein inhibits the endotoxic activity of lipopolysaccharide and Gram-negative bacteria. J. Immunol. 180, 7546-7552
38. Chiang, S.C., Veldhuizen, E.J., Barnes, F.A., Craven, C.J., Haagsman, H.P. and Bingle, C.D. (2011) Identification and characterisation of the BPI/LBP/PLUNC-like gene repertoire in chickens reveals the absence of a LBP gene. Dev. Comp. Immunol. 35, 285-295
39. Grube, B.J., Cochane, C.G., Ye, R.D., Green, C.E., McPhail, M.E., Ulevitch, R.J. and Tobias, P.S. (1994) Lipopolysaccharide binding protein expression in primary human hepatocytes and HepG2 hepatoma cells. J. Biol. Chem. 269, 8477-8482
40. Schumann, R.R., Kirschning, C.J., Unbehaun, A., Aberle, H.P., Knope, H.P., Lamping, N., Ulevitch, R.J. and Herrmann, F. (1996) The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins. Mol. Cell. Biol. 16, 3490-3503
41. Kirschning, C.J., Unbehaun, A., Fiedler, G., Hallatschek, W., Lamping, N., Pfeil, D. and Schumann, R.R. (1997) The transcriptional activation pattern of lipopolysaccharide binding protein (LBP) involving transcription factors AP-1 and C/EBPβ. Immunobiology 198, 124-135 (Pubitemid 28021388)
42. Hallatschek, W., Fiedler, G., Kirschning, C.J., Creutzburg, F., Lamping, N., Nussler, A. and Schumann, R.R. (2004) Inhibition of hepatic transcriptional induction of lipopolysaccharide-binding protein by transforming-growth-factor β1. Eur. J. Immunol. 34, 1441-1450 (Pubitemid 39256024)
43. Klein, R.D., Su, G.L., Aminlari, A., Alarcon, W.H. and Wang, S.C. (1998) Pulmonary LPS-binding protein (LBP) upregulation following LPS-mediated injury. J. Surg. Res. 78, 42-47
44. Vreugdenhil, A.C., Dentener, M.A., Snoek, A.M., Greve, J.W. and Buurman, W.A. (1999) Lipopolysaccharide binding protein and serum amyloid A secretion by human intestinal epithelial cells during the acute phase response. J. Immunol. 163, 2792-2798 (Pubitemid 29399207)
45. Malm, J., Nordahl, E.A., Bjartell, A., Sorensen, O.E., Frohm, B., Dentener, M.A. and Egesten, A. (2005) Lipopolysaccharide-binding protein is produced in the epididymis and associated with spermatozoa and prostasomes. J. Reprod. Immunol. 66, 33-43
46. Dentener, M.A., Vreugdenhil, A.C., Hoet, P.H., Vernooy, J.H., Nieman, F.H., Heumann, D., Janssen, Y.M., Buurman, W.A. and Wouters, E.F. (2000) Production of the acute-phase protein lipopolysaccharide-binding protein by respiratory type II epithelial cells: implications for local defense to bacterial endotoxins. Am. J. Respir. Cell Mol. Biol. 23, 146-153
47. Wang, S.C., Klein, R.D., Wahl, W.L., Alarcon, W.H., Garg, R.J., Remick, D.G. and Su, G.L. (1998) Tissue coexpression of LBP and CD14 mRNA in a mouse model of sepsis. J. Surg. Res. 76, 67-73
48. Brass, D.M., Savov, J.D., Whitehead, G.S., Maxwell, A.B. and Schwartz, D.A. (2004) LPS binding protein is important in the airway response to inhaled endotoxin. J. Allergy Clin. Immunol. 114, 586-592
49. Gamble, L., Bagby, G.J., Quinton, L.J., Happel, K.I., Mizgerd, J.P., Zhang, P. and Nelson, S. (2009) The systemic and pulmonary LPS binding protein response to intratracheal lipopolysaccharide. Shock 31, 212-217
50. Opal, S.M., Palardy, J.E., Marra, M.N., Fisher, Jr, C.J., McKelligon, B.M. and Scott, R.W. (1994) Relative concentrations of endotoxin-binding proteins in body fluids during infection. Lancet 344, 429-431 (Pubitemid 24248243)
51. Opal, S.M., Scannon, P.J., Vincent, J.L., White, M., Carroll, S.F., Palardy, J.E., Parejo, N.A., Pribble, J.P. and Lemke, J.H. (1999) Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J. Infect. Dis. 180, 1584-1589
52. Zweigner, J., Gramm, H.J., Singer, O.C., Wegscheider, K. and Schumann, R.R. (2001) High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood 98, 3800-3808
53. Thompson, P.A., Tobias, P.S., Viriyakosol, S., Kirkland, T.N. and Kitchens, R.L. (2003) Lipopolysaccharide (LPS)-binding protein inhibits responses to cell-bound LPS. J. Biol. Chem. 278, 28367-28371
54. Kitchens, R.L. and Thompson, P.A. (2005) Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J. Endotoxin Res. 11, 225-229 (Pubitemid 41358857)
55. Wurfel, M.M. and Wright, S.D. (1995) Lipopolysaccharide (LPS) binding protein catalyzes binding of LPS to lipoproteins. Prog. Clin. Biol. Res. 392, 287-295
56. Vreugdenhil, A.C., Rousseau, C.H., Hartung, T., Greve, J.W., van 't Veer, C. and Buurman, W.A. (2003) Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons. J. Immunol. 170, 1399-1405
57. Lamping, N., Dettmer, R., Schroder, N.W., Pfeil, D., Hallatschek, W., Burger, R. and Schumann, R.R. (1998) LPS-binding protein protects mice from septic shock caused by LPS or Gram-negative bacteria. J. Clin. Invest. 101, 2065-2071
58. Minter, R.M., Bi, X., Ben-Josef, G., Wang, T., Hu, B., Arbabi, S., Hemmila, M.R., Wang, S.C., Remick, D.G. and Su, G.L. (2009) LPS-binding protein mediates LPS-induced liver injury and mortality in the setting of biliary obstruction. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G45-G54
59. Erwin, P.J., Lewis, H., Dolan, S., Tobias, P.S., Schumann, R.R., Lamping, N., Wisdom, G.B., Rowlands, B.J. and Halliday, M.I. (2000) Lipopolysaccharide binding protein in acute pancreatitis. Crit. Care Med. 28, 104-109
60. Knapp, S., Florquin, S., Golenbock, D.T. and van der Poll, T. (2006) Pulmonary lipopolysaccharide (LPS)-binding protein inhibits the LPS-induced lung inflammation in vivo. J. Immunol. 176, 3189-3195
61. Jack, R.S., Fan, X., Bernheiden, M., Rune, G., Ehlers, M., Weber, A., Kirsch, G., Mentel, R., Furll, B., Freudenberg, M. et al. (1997) Lipopolysaccharide-binding protein is required to combat a murine Gram-negative bacterial infection. Nature 389, 742-745 (Pubitemid 27458962)
62. Yang, K.K., Dorner, B.G., Merkel, U., Ryffel, B., Schutt, C., Golenbock, D., Freeman, M.W. and Jack, R.S. (2002) Neutrophil influx in response to a peritoneal infection with Salmonella is delayed in lipopolysaccharide-binding protein or CD14-deficient mice. J. Immunol. 169, 4475-4480
63. Wurfel, M.M., Monks, B.G., Ingalls, R.R., Dedrick, R.L., Delude, R., Zhou, D., Lamping, N., Schumann, R.R., Thieringer, R., Fenton, M.J. et al. (1997) Targeted deletion of the lipopolysaccharide (LPS)-binding protein gene leads to profound suppression of LPS responses ex vivo, whereas in vivo responses remain intact. J. Exp. Med. 186, 2051-2056 (Pubitemid 28013690)
64. Branger, J., Florquin, S., Knapp, S., Leemans, J.C., Pater, J.M., Speelman, P., Golenbock, D.T. and van der Poll, T. (2004) LPS-binding protein-deficient mice have an impaired defense against Gram-negative but not Gram-positive pneumonia. Int. Immunol. 16, 1605-1611
65. Gallay, P., Heumann, D., Le Roy, D., Barras, C. and Glauser, M.P. (1993) Lipopolysaccharide-binding protein as a major plasma protein responsible for endotoxemic shock. Proc. Natl. Acad. Sci. U.S.A. 90, 9935-9938
66. Gallay, P., Heumann, D., Le Roy, D., Barras, C. and Glauser, M.P. (1994) Mode of action of anti-lipopolysaccharide-binding protein antibodies for prevention of endotoxemic shock in mice. Proc. Natl. Acad. Sci. U.S.A. 91, 7922-7926
67. Weber, J.R., Freyer, D., Alexander, C., Schroder, N.W., Reiss, A., Kuster, C., Pfeil, D., Tuomanen, E.I. and Schumann, R.R. (2003) Recognition of pneumococcal peptidoglycan: an expanded, pivotal role for LPS binding protein. Immunity 19, 269-279 (Pubitemid 37011341)
68. Schröder, N.W.J., Heine, H., Alexander, C., Manukyan, M., Eckert, J., Hamann, L., Gobel, U.B. and Schumann, R.R. (2004) Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses. J. Immunol. 173, 2683-2691 (Pubitemid 39063129)
69. Schroder, N.W., Opitz, B., Lamping, N., Michelsen, K.S., Zahringer, U., Gobel, U.B. and Schumann, R.R. (2000) Involvement of lipopolysaccharide binding protein, CD14, and Toll-like receptors in the initiation of innate immune responses by Treponema glycolipids. J. Immunol. 165, 2683-2693 (Pubitemid 30660718)
70. Schroder, N.W., Eckert, J., Stubs, G. and Schumann, R.R. (2008) Immune responses induced by spirochetal outer membrane lipoproteins and glycolipids. Immunobiology 213, 329-340 (Pubitemid 351479861)
71. Schroder, N.W. and Schumann, R.R. (2005) Non-LPS targets and actions of LPS binding protein (LBP). J. Endotoxin Res. 11, 237-242 (Pubitemid 41358859)
72. Schroder, N.W., Morath, S., Alexander, C., Hamann, L., Hartung, T., Zahringer, U., Gobel, U.B., Weber, J.R. and Schumann, R.R. (2003) Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J. Biol. Chem. 278, 15587-15594
73. Hermann, C., Spreitzer, I., Schroder, N.W., Morath, S., Lehner, M.D., Fischer, W., Schutt, C., Schumann, R.R. and Hartung, T. (2002) Cytokine induction by purified lipoteichoic acids from various bacterial species: role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-γ release. Eur. J. Immunol. 32, 541-551
74. Gutsmann, T., Haberer, N., Carroll, S.F., Seydel, U. and Wiese, A. (2001) Interaction between lipopolysaccharide (LPS), LPS-binding protein (LBP), and planar membranes. Biol. Chem. 382, 425-434
75. Mueller, M., Brandenburg, K., Dedrick, R., Schromm, A.B. and Seydel, U. (2005) Phospholipids inhibit lipopolysaccharide (LPS)-induced cell activation: a role for LPS-binding protein. J. Immunol. 174, 1091-1096 (Pubitemid 40094306)
76. Muller, M., Scheel, O., Lindner, B., Gutsmann, T. and Seydel, U. (2003) The role of membrane-bound LBP, endotoxin aggregates, and the MaxiK channel in LPS-induced cell activation. J. Endotoxin Res. 9, 181-186 (Pubitemid 36722598)
77. Sorensen, T.I., Nielsen, G.G., Andersen, P.K. and Teasdale, T.W. (1988) Genetic and environmental influences on premature death in adult adoptees. N. Engl. J. Med. 318, 727-732
78. Picard, C., Puel, A., Bonnet, M., Ku, C.L., Bustamante, J., Yang, K., Soudais, C., Dupuis, S., Feinberg, J., Fieschi, C. et al. (2003) Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299, 2076-2079 (Pubitemid 36383736)
79. Ku, C.L., Yang, K., Bustamante, J., Puel, A., von Bernuth, H., Santos, O.F., Lawrence, T., Chang, H.H., Al-Mousa, H., Picard, C. and Casanova, J.L. (2005) Inherited disorders of human Toll-like receptor signaling: immunological implications. Immunol. Rev. 203, 10-20
80. Schroder, N.W. and Schumann, R.R. (2005) Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect. Dis. 5, 156-164
81. Schroder, N.W., Diterich, I., Zinke, A., Eckert, J., Draing, C., von Baehr, V., Hassler, D., Priem, S., Hahn, K., Michelsen, K.S. et al. (2005) Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J. Immunol. 175, 2534-2540
82. Mockenhaupt, F.P., Cramer, J.P., Hamann, L., Stegemann, M.S., Eckert, J., Oh, N.R., Otchwemah, R.N., Dietz, E., Ehrhardt, S., Schroder, N.W. et al. (2006) Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria. Proc. Natl. Acad. Sci. U.S.A. 103, 177-182
83. Oh, D.Y., Schumann, R.R., Hamann, L., Neumann, K., Worm, M. and Heine, G. (2009) Association of the Toll-like receptor 2 A-16934T promoter polymorphism with severe atopic dermatitis. Allergy 64, 1608-1615
84. Oh, D.Y., Baumann, K., Hamouda, O., Eckert, J.K., Neumann, K., Kucherer, C., Bartmeyer, B., Poggensee, G., Oh, N., Pruss, A. et al. (2009) A frequent functional Toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression. AIDS 23, 297-307
85. Oh, D.Y., Taube, S., Hamouda, O., Kucherer, C., Poggensee, G., Jessen, H., Eckert, J.K., Neumann, K., Storek, A., Pouliot, M. et al. (2008) A functional Toll-like receptor 8 variant is associated with HIV disease restriction. J. Infect. Dis. 198, 701-709
86. Ferwerda, B., McCall, M.B., Alonso, S., Giamarellos-Bourboulis, E.J., Mouktaroudi, M., Izagirre, N., Syafruddin, D., Kibiki, G., Cristea, T., Hijmans, A. et al. (2007) TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc. Natl. Acad. Sci. U.S.A. 104, 16645-16650
87. Ferwerda, B., Alonso, S., Banahan, K., McCall, M.B., Giamarellos- Bourboulis, E.J., Ramakers, B.P., Mouktaroudi, M., Fain, P.R., Izagirre, N., Syafruddin, D. et al. (2009) Functional and genetic evidence that the Mal/TIRAP allele variant 180L has been selected by providing protection against septic shock. Proc. Natl. Acad. Sci. U.S.A. 106, 10272-10277
88. Hubacek, J.A., Pitha, J., Skodova, Z., Adamkova, V., Podrapska, I., Schmitz, G. and Poledne, R. (2002) Polymorphisms in the lipopolysaccharide- binding protein and bactericidal/permeability-increasing protein in patients with myocardial infarction. Clin. Chem. Lab Med. 40, 1097-1100
89. Hubacek, J.A., Stuber, F., Frohlich, D., Book, M., Wetegrove, S., Ritter, M., Rothe, G. and Schmitz, G. (2001) Gene variants of the bactericidal/ permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: gender-specific genetic predisposition to sepsis. Crit. Care Med. 29, 557-561
90. Flores, C., Perez-Mendez, L., Maca-Meyer, N., Muriel, A., Espinosa, E., Blanco, J., Sanguesa, R., Muros, M., Garcia, J.G. and Villar, J. (2009) A common haplotype of the LBP gene predisposes to severe sepsis. Crit. Care Med. 37, 2759-2766